Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Clemente-Casares

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Immunology Letters|January 11, 2014
Nanomedicine in autoimmunityXavier Clemente-Casares, Pere Santamaria
Viruses|February 28, 2023
COVID-19: The Many Ways to Hurt Your HeartAklima Akter, Xavier Clemente-Casares
Frontiers in Immunology|April 10, 2023
Maternal provisions in type 1 diabetes: Evidence for both protective & pathogenic potentialErin Strachan, Xavier Clemente-Casares, Sue Tsai
Cellular and Molecular Life Sciences : CMLS|June 15, 2011
CD8(+) Tregs in autoimmunity: learning "self"-control from experienceSue Tsai, Xavier Clemente-Casares, Pere Santamaria
Journal of Visualized Experiments : Jove|September 11, 2018
Isolation and Identification of Extravascular Immune Cells of the HeartLaura Aronoff, Slava Epelman, Xavier Clemente-Casares
Journal of Molecular Medicine (Berlin, Germany)|April 19, 2011
Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a "one size fits all" approach?Xavier Clemente-Casares, Sue Tsai, Yang Yang, et al.
Cold Spring Harbor Perspectives in Medicine|February 23, 2012
Antigen-specific therapeutic approaches in Type 1 diabetesXavier Clemente-Casares, Sue Tsai, Carol Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2011
Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependentAfshin Shameli, Xavier Clemente-Casares, Jinguo Wang, et al.
Frontiers in Cell and Developmental Biology|December 5, 2022
Mechanosensing in macrophages and dendritic cells in steady-state and diseaseMegan Lee, Huixun Du, Daniel A Winer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2013
Dendritic cell-dependent in vivo generation of autoregulatory T cells by antidiabetogenic MHC class IISue Tsai, Pau Serra, Xavier Clemente-Casares, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Immunology Letters|January 11, 2014
Nanomedicine in autoimmunityXavier Clemente-Casares, Pere Santamaria
Viruses|February 28, 2023
COVID-19: The Many Ways to Hurt Your HeartAklima Akter, Xavier Clemente-Casares
Frontiers in Immunology|April 10, 2023
Maternal provisions in type 1 diabetes: Evidence for both protective & pathogenic potentialErin Strachan, Xavier Clemente-Casares, Sue Tsai
Cellular and Molecular Life Sciences : CMLS|June 15, 2011
CD8(+) Tregs in autoimmunity: learning "self"-control from experienceSue Tsai, Xavier Clemente-Casares, Pere Santamaria
Journal of Visualized Experiments : Jove|September 11, 2018
Isolation and Identification of Extravascular Immune Cells of the HeartLaura Aronoff, Slava Epelman, Xavier Clemente-Casares
Journal of Molecular Medicine (Berlin, Germany)|April 19, 2011
Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a "one size fits all" approach?Xavier Clemente-Casares, Sue Tsai, Yang Yang, et al.
Cold Spring Harbor Perspectives in Medicine|February 23, 2012
Antigen-specific therapeutic approaches in Type 1 diabetesXavier Clemente-Casares, Sue Tsai, Carol Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2011
Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependentAfshin Shameli, Xavier Clemente-Casares, Jinguo Wang, et al.
Frontiers in Cell and Developmental Biology|December 5, 2022
Mechanosensing in macrophages and dendritic cells in steady-state and diseaseMegan Lee, Huixun Du, Daniel A Winer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2013
Dendritic cell-dependent in vivo generation of autoregulatory T cells by antidiabetogenic MHC class IISue Tsai, Pau Serra, Xavier Clemente-Casares, et al.
Pageof 4